Ko-3290

• CAT Number: I013582
• CAS Number: 79848-61-6
• Molecular Formula: C₁₉H₂₅N₃O₃
• Molecular Weight: 343.42
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: DMSO
• IUPAC Name: N-[3-cyano-4-[2-hydroxy-3-(2-methylbut-3-yn-2-ylamino)propoxy]phenyl]-2-methylpropanamide
• InChI: InChI=1S/C19H25N3O3/c1-6-19(4,5)21-11-16(23)12-25-17-8-7-15(9-14(17)10-20)22-18(24)13(2)3/h1,7-9,13,16,21,23H,11-12H2,2-5H3,(H,22,24)
• InChIKey: OPEGAEBRVGIBAS-UHFFFAOYSA-N
• SMILES: CC(C)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C#C)O)C#N

Ko-3290（Cat No.:I013582）is a small molecule inhibitor developed to target and inhibit specific enzymes involved in cellular signaling pathways, particularly those related to cancer and inflammation. It has shown potential in preclinical studies as an anti-cancer agent, possibly by affecting mechanisms that drive tumor cell growth, survival, and metastasis. The compound has also been investigated for its role in modulating immune responses and reducing inflammation. Research on Ko-3290 is still in the early stages, with ongoing studies aimed at evaluating its safety, efficacy, and potential therapeutic applications for various cancers and inflammatory diseases.